Christopher Watt
Nessuna posizione attualmente
Profilo
Christopher Watt worked as a Senior Vice President-Finance at Tetraphase Pharmaceuticals, Inc. from 2017 to 2020 and as a Vice President-Finance at Biogen, Inc. from 2015 to 2017.
Prior to that, he earned an MBA from the University of Michigan and an undergraduate degree from Colby College.
Precedenti posizioni note di Christopher Watt
| Società | Posizione | Fine |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 28/07/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Formazione di Christopher Watt
| Colby College | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Watt